Optimization of Cervical Nodal Clinical Tumor Volume for Early and Medium Stage Nasopharyngeal Carcinoma
Status:
Not yet recruiting
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
The regional failure rate of early to mid-stage nasopharyngeal carcinoma is low and
recurrence is mainly in high-dose areas within the target area. The purpose of this study was
to investigate whether a strategy of irradiating the affected site to narrow the clinical
target area of high-risk lymph nodes (ISI) could significantly reduce treatment-related
toxicities without compromising regional control rates compared with a conventional regimen
(ERI).